06/08/2014 - 18:00 The Food and Drug Administration has issued a warning about adverse events associated with use of the Expression intranasal splint as a dermal filler Visit websiteField of Interest: DermatologyCategories: SAN || Clinical NewsOBGYN || Preventive Care and WellnessOBGYN || FDA & CDCOBGYN || NewsFPN || DermatologyFPN || FDA & CDCFPN || NewsIMN || DermatologyIMN || FDA & CDCIMN || NewsNews Feed: Internal Medicine News - Dermatology
